Adipocytes produce RBP4, and its levels typically increase with obesity, which leads to the hypothesis that adipose tissue and hepatic-derived RBP4 could play different roles in cardiometabolic diseases. Here, RBP4 is linked to obesity due to melanocortin 4 receptor deficiency.